Skip to main content

MoneyWorks4Me

Kerala Ayurveda - Quaterly Results

13 Nov 2026 Evaluate
The Revenue for the quarter ended  September 2026 of Rs. 238.37 millions grew by 11.97 % from Rs. 212.89 millions.The Net Loss for the quarter ended September 2026 is Rs. -65.74 millions as compared to Net Loss of Rs. -54.00 millions of corresponding quarter ended September 2025 Operating profit Margin for the quarter ended September 2026 further decreased to -26.62% as compared to -27.79% of corresponding quarter ended September 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 238.37 212.89 11.97 463.66 388.55 19.33 854.85 726.89 17.60
Other Income 16.73 22.58 -25.91 29.51 122.57 -75.92 179.35 51.71 246.84
PBIDT -26.62 -27.79 -4.21 -64.77 17.93 -461.24 -50.81 -74.16 -31.49
Interest 32.16 25.43 26.46 60.25 33.13 81.86 72.70 39.16 85.65
PBDT -58.78 -53.22 10.45 -125.02 -15.20 722.50 -123.51 -113.32 8.99
Depreciation 9.03 5.46 65.38 23.08 17.72 30.25 35.95 21.51 67.13
PBT -67.81 -58.68 15.56 -148.10 -32.92 349.88 -159.46 -134.83 18.27
TAX -2.07 -4.68 -55.77 -5.68 0.40 -1520.00 -12.05 2.98 -504.36
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -65.74 -54.00 21.74 -142.42 -33.32 327.43 -147.41 -137.81 6.97
Equity 129.95 120.60 7.75 129.95 120.60 7.75 126.90 120.32 5.47
PBIDTM(%) -11.17 -13.05 -14.45 -13.97 4.61 -402.72 -5.94 -10.20 -41.74
Peers
Company Name CMP
Sun Pharma. Inds. 1894.90
Dr. Reddys Labs. 1391.10
Cipla 1409.75
Lupin 1985.85
Zydus Lifesciences 1192.00
View more..